切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2026, Vol. 16 ›› Issue (05) : 266 -277. doi: 10.3877/cma.j.issn.2095-1221.2026.05.002

论著

关节腔注射脂肪间充质干细胞对碘乙酸钠诱导大鼠急性软骨损伤的抗炎及组织学修复作用
李文芳1, 董孟炜2, 杨万彭2, 巴特3,4, 南楠3,4, 刘杨2,3,4, 郝慧琴2,3,4,†()   
  1. 1030619 晋中,山西中医药大学第一临床学院
    2030619 晋中,山西中医药大学基础医学院
    3030619 晋中,山西中医药大学国家中医药管理局中医药基因表达调节实验室
    4030619 晋中,山西省中医药交叉创新工程研究中心
  • 收稿日期:2026-03-23 出版日期:2026-10-01
  • 通信作者: 郝慧琴
  • 基金资助:
    国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023022); 山西省优秀研究生导师团队建设项目(2024TD33); 风湿免疫病中西医结合基础研究学科建设项目(2026XK29); 山西省重点实验室建设项目(zyyyjs2024021); 山西省中医药科技创新工程项目(2024KJZY006); 山西省教育厅科技创新项目(2024L269)

Anti-inflammatory and histological repair effects of intra-articular injection of adipose-derived mesenchymal stem cells on acute cartilage injury induced by sodium iodoacetate in rats

Wenfang Li1, Mengwei Dong2, Wanpeng Yang2, Te Ba3,4, Nan Nan3,4, Yang Liu2,3,4, Huiqin Hao2,3,4,†()   

  1. 1First Clinical College, Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Jinzhong 030619, China
    2School of Basic Medicine, Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Jinzhong 030619, China
    3Laboratory of Gene Regulation by Traditional Chinese medicine, Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Jinzhong 030619, China
    4Engineering Research Center for Cross-Innovation in Chinese Traditional Medicine of Shanxi Province, Jinzhong 030619, China
  • Received:2026-03-23 Published:2026-10-01
  • Corresponding author: Huiqin Hao
引用本文:

李文芳, 董孟炜, 杨万彭, 巴特, 南楠, 刘杨, 郝慧琴. 关节腔注射脂肪间充质干细胞对碘乙酸钠诱导大鼠急性软骨损伤的抗炎及组织学修复作用[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(05): 266-277.

Wenfang Li, Mengwei Dong, Wanpeng Yang, Te Ba, Nan Nan, Yang Liu, Huiqin Hao. Anti-inflammatory and histological repair effects of intra-articular injection of adipose-derived mesenchymal stem cells on acute cartilage injury induced by sodium iodoacetate in rats[J/OL]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2026, 16(05): 266-277.

目的

探讨脂肪间充质干细胞(ADSCs)对膝骨关节炎(KOA)大鼠软骨损伤及炎症反应的影响及作用持续时间。

方法

将45只雄性SD大鼠随机分为空白组、模型组、治疗组。制备KOA模型14 d后,治疗组大鼠在关节腔注射1 × 106个ADSCs/50 μL,空白组和KOA模型组大鼠注射等量生理盐水,每周1次,连续注射4次,观察4周、8周及12周各指标变化,各时间点设立独立的空白组、模型组及治疗组(n = 5)。监测并记录各组大鼠的机械痛阈值和热痛阈值,取材后通过micro-CT、HE染色、番红O-固绿染色和阿利新蓝染色观察软骨损伤退变程度;免疫组化检测Ⅱ型胶原(COL2A1)、聚集蛋白聚糖(ACAN)的蛋白表达;ELISA法检测关节腔冲洗液中的炎症因子IL-1β、TNF-α的表达水平。采用双因素析因设计方差分析分析分组与观察时间的主效应,两两比较采用Bonferroni事后检验。

结果

各组机械痛阈值、骨体积分数、骨小梁分离度、Mankin评分、OARSI评分、COL2A1及IL-1β的分组主效应具有统计学意义(P 均 < 0.05),时间主效应无统计学意义(P 均 > 0.05);热痛阈值、骨小梁厚度、骨小梁数目、ACAN、TNF-α的分组主效应与时间主效应均有统计学意义(P 均 < 0.05)。与空白组相比,模型组大鼠机械痛阈值、热痛阈值、骨体积分数、骨小梁厚度及骨小梁数目[4周:(0.92 ± 0.02)比(1.17 ± 0.05)mm-1,8周:(0.81 ± 0.07)比(1.17 ± 0.04)mm-1,12周:(0.75 ± 0.03)比(1.16 ± 0.05) mm-1]均降低,骨小梁分离度、Mankin评分及OARSI评分增加,COL2A1、ACAN蛋白的阳性细胞表达率降低;IL-1β[4 周:(53.87 ± 2.32)比(29.71 ± 3.26)pg/mL,8周:(56.31 ± 5.85)比(27.70 ± 2.69) pg/mL、(58.59 ± 3.36)比(25.34 ± 3.23)pg/mL]和TNF-α表达水平[4周:(142.52 ± 14.33)比(71.52 ± 6.68) pg/mL,8周:(153.94 ± 7.36)比(75.45 ± 2.78)pg/mL、(160.60 ± 10.93)比(75.67 ± 3.20) pg/mL]均升高(P 均 < 0.05)。与模型组相比,治疗组机械痛阈值、热痛阈值升高,骨体积分数、骨小梁厚度及骨小梁数目[4周:(1.09 ± 0.04)比(0.92 ± 0.02)mm-1,8周:(1.02 ± 0.15)比(0.81 ± 0.07)mm-1,12周:(1.00 ± 0.05)比(0.75 ± 0.03)mm-1]均增加,骨小梁分离度、Mankin评分及OARSI评分降低,COL2A1、ACAN蛋白的阳性细胞表达率升高,IL-1β[4 周:(37.15 ± 7.16)比(53.87 ± 2.32) pg/mL,8周:(41.56 ± 7.24)比(56.31 ± 5.85)pg/mL、12周:(42.39 ± 3.41)比(58.59 ± 3.36) pg/mL]和TNF-α表达水平[4周:(84.49 ± 7.12)比(142.52 ± 14.33)pg/mL,8周:(88.22 ± 3.25)比(153.94 ± 7.36) pg/mL、12周:(90.31 ± 5.29)比(160.60 ± 10.93)pg/mL]降低(P 均 < 0.05)。与4周模型组相比,12周模型组的骨小梁厚度增加,骨小梁数目降低,ACAN蛋白的阳性细胞表达率降低,TNF-α的表达水平显著升高(P 均 < 0.05)。

结论

ADSCs可以缓解KOA的疼痛症状,减轻关节炎症,可能通过促进软骨生成修复软骨损伤,且疗效具有一定的时效性,可为临床干细胞治疗KOA的时效特征提供实验依据。

Objective

To explore the effects and duration of adipose-derived mesenchymal stem cells (ADSCs) on cartilage injury and inflammatory response in knee osteoarthritis (KOA) rats.

Methods

Forty-five male SD rats were divided into the blank group, model group and treatment group randomly. Fourteen days after the KOA model establishment, the rats in the treatment group were injected with 1×106 ADSCs/50 μL into the articular cavity while rats in the blank group and the KOA model group were injected with the same volume of normal saline once a week for four consecutive injections. The rats were observed at 4 weeks, 8 weeks and 12 weeks (n = 5) after the first injection. Independent blank group, model group and treatment group were set up at each observation time point. The mechanical pain threshold and thermal pain threshold of rats in each group were monitored and recorded. The degree of cartilage degeneration was observed by micro CT, HE-staining, Safranine O-fast green staining and Alcian blue staining. The protein expressions of collagen Ⅱ (COL2A1) and aggrecan (ACAN) were detected by immunohistochemistry. The expression levels of inflammatory factors IL-1β and TNF-α in articular cavity lavage fluid were detected by ELISA. Two-way factorial design ANOVA was used to analyze the main effect of group and observation time for all measurement data, and Bonferroni post-test was used for pairwise comparison.

Results

The main effects of group in mechanical pain threshold, bone volume fraction, trabecular bone separation, Mankin score, OARSI score, COL2A1 and IL-1β in each group were statistically significant (all P < 0.05), while there was no significant difference in the main effects of time (all P > 0.05); The main effects of group and time were significant in terms of thermal pain threshold, trabecular thickness, trabecular number, ACAN and TNF-α (all P < 0.05). Compared with the blank group, the mechanical pain threshold, the thermal pain threshold, bone volume fraction, trabecular thickness and trabecular number [4 weeks: (0.92 ± 0.02) vs (1.17 ± 0.05) mm-1, 8 weeks: (0.81 ± 0.07) vs (1.17 ± 0.04) mm-1, 12 weeks: (0.75 ± 0.03) vs (1.16 ± 0.05) mm-1] as well as positive cell expression rate of COL2A1 and ACAN protein were significantly decreased in the model group, while the bone trabecular separation, Mankin score, OARSI score and the expression levels of IL-1β [4 weeks: (53.87 ± 2.32) vs (29.71 ± 3.26) pg/mL, 8 weeks: (56.31 ± 5.85) vs (27.70 ± 2.69) pg/mL, (58.59 ± 3.36) vs (25.34 ± 3.23) pg/mL] and TNF-α [4 weeks: (142.52 ± 14.33) vs (71.52 ± 6.68) pg/mL, 8 weeks: (153.94 ± 7.36) vs (75.45 ± 2.78) pg/mL, (160.60 ± 10.93) vs (75.67 ± 3.20) pg/mL] were significantly increased (all P < 0.05). Compared with the model group, the mechanical pain threshold, the thermal pain threshold, the bone volume fraction, trabecular thickness, and trabecular number [4 weeks: (1.09 ± 0.04) vs (0.92 ± 0.02) mm-1, 8 weeks: (1.02 ± 0.15) vs (0.81 ± 0.07) mm-1, 12 weeks: (1.00 ± 0.05) vs (0.75 ± 0.03) mm-1] and positive cell expression rate in the COL2A1 and ACAN protein was significantly increased in the treatment group, while the bone trabecular separation, Mankin score, OARSI score and the expression level of IL-1β [4 weeks: (37.15 ± 7.16) vs (53.87 ± 2.32) pg/mL, 8 weeks: (41.56 ± 7.24) vs (56.31 ± 5.85) pg/mL, 12 weeks: (42.39 ± 3.41) vs (58.59 ± 3.36) pg/mL] and TNF-α [4 weeks: (84.49 ± 7.12) vs (142.52 ± 14.33) pg/mL, 8 weeks: (88.22 ± 3.25) vs (153.94 ± 7.36) pg/mL, 12 weeks: (90.31 ± 5.29) vs (160.60 ± 10.93) pg/mL] were significantly decreased (all P < 0.05). Compared with the 4-week model group, the trabecular thickness and the expression level of TNF-α in the 12-week model group were significantly increased, while the number of trabeculae and the positive cell expression rate of ACAN protein were significantly decreased (all P < 0.05).

Conclusions

ADSCs can relieve the pain symptoms of KOA, reduce joint inflammation, and may repair cartilage damage by promoting chondrogenesis, which has a certain timeliness, providing experimental basis for certain timeliness characteristics of clinical stem cell therapy for KOA.

图1 膝骨关节炎大鼠造模方法
图2 ADSCs的形态与增殖曲线注:ADSCs为脂肪间充质干细胞;a图为倒置生物显微镜下的ADSCs形态观察(×100);b图为ADSCs的增殖曲线,10%、2.5%为培养基中胎牛血清的含量,2.5 : 1、1 : 1为培养基中胰岛素样生长因子-1体积与青链霉素体积的比值,n = 5
图3 流式细胞术对ADSCs特异性表面标志物分析结果注:ADSCs为脂肪间充质干细胞;流式结果显示ADSCs高表达CD73、CD90和CD105,低表达CD34和CD45
图4 倒置生物显微镜下观察ADSCs成脂/成骨/成软骨三系诱导分化及相应染色鉴定(×200)注:a图为ADSCs成脂分化鉴定,油红O染色显示脂滴阳性;b图为ADSCs成骨分化鉴定,茜素红染色显示钙盐沉积阳性;c图为ADSCs成软骨分化鉴定,阿利新蓝染色显示酸性黏多糖阳性
图5 ADSCs对KOA大鼠机械痛、热痛阈值的影响注:*P < 0.05,**P < 0.01,***P < 0.001,n = 5
图6 ADSCs对KOA软骨立体光学解剖结构的影响注:随着时间的进展,模型组大鼠膝关节面逐渐粗糙并伴炎性增生,治疗组炎性增生有所减少,软骨表面附着新生的透明软骨
图7 ADSCs对KOA大鼠膝关节micro-CT骨微结构及骨参数的影响注:a图为大鼠膝关节2D、3D冠状面和矢状面,随着时间进展,模型组骨侵蚀加重,骨赘增多,治疗组骨侵蚀有所减轻;b ~ e图为各组大鼠膝关节骨参数:骨体积分数、骨小梁厚度、骨小梁分离度、骨小梁数目,*P < 0.05,**P < 0.01,***P < 0.001,n = 3
图8 ADSCs对KOA大鼠膝关节的病理学结果及评分的影响注:a图为切片扫描仪观察大鼠膝关节HE染色、番红O-固绿染色、阿利新蓝染色,随着时间进展,模型组糖胺聚糖与胶原蛋白丢失愈发明显,骨损伤严重,治疗组糖胺聚糖与胶原蛋白表达有所恢复,骨损伤有所改善(×100) ;b、c图为各组大鼠Mankin评分和OARSI评分比较,*P < 0.05,**P < 0.01,***P < 0.001,n = 5
图9 ADSCs对KOA大鼠软骨组织中COL2A1、ACAN蛋白表达的影响注:a图为大鼠膝关节软骨组织中COL2A1、ACAN蛋白的免疫组化染色结果,随着时间进展,模型组的COL2A1、ACAN蛋白表达减少,治疗组COL2A1、ACAN蛋白表达有所改善(×200);b、c图为各组大鼠软骨组织中COL2A1、ACAN蛋白的阳性细胞表达率比较。***P < 0.001,n = 3
表1 ADSCs对KOA大鼠关节腔滑液炎症因子表达的影响( ± s)
1
中华中医药学会. 膝骨关节炎中西医结合诊疗指南(2023年版)[J]. 中医正骨, 2023,35(6):1-10.
2
Cui A, Li H, Wang D, et al. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies[J]. EClinicalMed, 2020, 29-30:100587.
3
Clouet J, Vinatier C, Merceron C, et al. From osteoarthritis treatments to future regenerative therapies for cartilage[J]. Drug Discov Today, 2009, 14(19-20):913-925.
4
Steinmetz JD, Culbreth GT, Haile LM, et al. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2023, 5(9):e508-e522.
5
Kongtharvonskul J, Anothaisintawee T, McEvoy M, et al. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis[J]. Eur J Med Res, 2015, 20(1):24.
6
Zhang J, Liu Y, Chen Y, et al. Adipose-derived stem cells: Current applications and future directions in the regeneration of multiple tissues[J]. Stem Cells Int, 2020, 2020:8810813.
7
Qin Y, Ge G, Yang P, et al. An update on adipose-derived stem cells for regenerative medicine: Where challenge meets opportunity[J]. Adv Sci (Weinh), 2023, 10(20):e2207334.
8
Shang Z, Wanyan P, Zhang B, et al. A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet?[J]. Stem Cell Res Ther, 2023, 14(1):91.
9
Park S, Rahaman KA, Kim Y, et al. Fostering tissue engineering and regenerative medicine to treat musculoskeletal disorders in bone and muscle[J]. Bioact Mater, 2024, 40:345-365.
10
吴德光. 关节内注射间充质干细胞治疗膝骨关节炎的疗效和安全性:随机对照试验的荟萃分析[D]. 广州:南方医科大学, 2021.
11
Liao T, Ding L, Wu P, et al. Chrysin attenuates the nlrp3 inflammasome cascade to reduce synovitis and pain in koa rats[J]. Drug Des Devel Ther, 2020, 14:3015-3027.
12
Yang W, Ke C, Yeh K, et al. Stromal-vascular fraction and adipose-derived stem cell therapies improve cartilage regeneration in osteoarthritis-induced rats[J]. Sci Rep, 2022, 12(1):2828.
13
谢有琼, 彭锐, 周晓红. 从肝论治针灸调控Bmal1介导ERK1/2抑制大鼠OA模型炎症的机制[J]. 时珍国医国药, 2022, 33(8):2033-2037.
14
Yuan X, Wang Q, Su W, et al. Electroacupuncture potentiates peripheral CB2 receptor-inhibited chronic pain in a mouse model of knee osteoarthritis[J]. J Pain Res, 2018, 11:2797-2808.
15
Li S, He Q, Chen B, et al. Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway[J]. Sci Rep, 2023, 13(1):13744.
16
Wu L, Zhang X, Yi C, et al. CD146-positive adipose-derived stem cells subpopulation enriched by albumin magnetic sphere ameliorates knee osteoarthritis pain and promotes cartilage repair[J]. J Orthop Surg Res, 2023, 18(1):969.
17
Lorenz J, Grassel S. Experimental osteoarthritis models in mice[J]. Methods Mol Biol, 2014, 1194:401-419.
18
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis[J]. Lancet, 2019, 393(10182):1745-1759.
19
Brophy RH, Fillingham YA. Aaos clinical practice guideline summary: Management of osteoarthritis of the knee (nonarthroplasty), third edition[J]. J Am Acad Orthop Surg, 2022, 30(9):e721-e729.
20
Wang Q, Mol MF, Bos PK, et al. Effect of intramuscular vs intra-articular glucocorticoid injection on pain among adults with knee osteoarthritis: The kis randomized clinical trial[J]. JAMA Netw Open, 2022, 5(4):e224852.
21
吕品雷, 苏约翰, 曹蕴, 等. 脂肪组织血管基质部分中克隆形成细胞治疗膝骨关节炎的能力[J]. 中国组织工程研究, 2015, 19(14): 2149-2154.
22
Pintore A, Notarfrancesco D, Zara A, et al. Intra-articular injection of bone marrow aspirate concentrate (BMAC) or adipose-derived stem cells (ADSCs) for knee osteoarthritis: a prospective comparative clinical trial[J]. J Orthop Surg Res, 2023, 18(1):350.
23
Kang J, Jie L, Fu H, et al. Adipose mesenchymal stem cells derived exosomes ameliorates koa cartilage damage and inflammation by activation of PINK1-mediated mitochondrial autophagy[J]. FASEB J, 2025, 39(14):e70811.
24
Zhang L, Li M, Li X, et al. Characteristics of sensory innervation in synovium of rats within different knee osteoarthritis models and the correlation between synovial fibrosis and hyperalgesia[J]. J Adv Res, 2022, 35:141-151.
25
Alves CJ, Couto M, Sousa DM, et al. Nociceptive mechanisms driving pain in a post-traumatic osteoarthritis mouse model[J]. Sci Rep, 2020, 10(1):15271.
26
Xu J, Yan L, Yan B, et al. Osteoarthritis pain model induced by Intra-Articular injection of Mono-Iodoacetate in rats[J]. J Vis Exp, 2020, 20:(159).
27
Yu H, Huang T, Lu WW, et al. Osteoarthritis Pain[J]. Int J Mol Sci, 2022, 23(9):4642.
28
Schuelert N, McDougall JJ. Grading of monosodium iodoacetate-induced osteoarthritis reveals a concentration-dependent sensitization of nociceptors in the knee joint of the rat[J]. Neurosci Lett, 2009, 465(2): 184-188.
29
Pu W, Liu Q, Xue S, et al. Time- and dose-related pathological changes in knee osteoarthritis rat model induced by monosodium iodoacetate[J]. Animal Model Exp Med, 2026, 9(1):21-30.
30
Liu R, Zhu T, Chu X, et al. Transcranial direct current stimulation alleviates chronic pain in knee osteoarthritis by modulating microglial and astrocytic polarization and neuroinflammation[J]. Life Sci, 2025, 376:123753.
31
闫文鑫, 张烨,郭景玥, 等. 间充质干细胞注射液对大鼠膝骨关节炎的影响[J]. 药物评价研究, 2023, 46(10):2179-2185.
32
娄本敬, 次旺, 严华韬, 等. 膝骨关节炎相关炎性因子研究进展[J]. 风湿病与关节炎, 2024, 13(02):67-71.
33
Zhao Q, Lin L, Guo Y, et al. Matrix metalloproteinase-13, NF-kappaB p65 and interleukin-1beta are associated with the severity of knee osteoarthritis[J]. Exp Ther Med, 2020, 19(6):3620-3626.
34
Liu K, Liu C, Zhang Z. lncRNA GAS5 acts as a ceRNA for miR-21 in suppressing PDGF-bb-induced proliferation and migration in vascular smooth muscle cells[J]. J Cell Biochem, 2019, 120(9):15233-15240.
35
Zampogna B, Parisi FR, Ferrini A, et al. Safety and efficacy of autologous adipose-derived stem cells for knee osteoarthritis in the elderly population: a systematic review[J]. J Clin Orthop Trauma, 2024, 59:102804.
36
Enomoto T, Akagi R, Ogawa Y, et al. Timing of Intra-Articular injection of synovial mesenchymal stem cells affects cartilage restoration in a partial thickness cartilage defect model in rats[J]. Cartilage, 2020, 11(1):122-129.
37
Satue M, Schuler C, Ginner N, et al. Intra-articularly injected mesenchymal stem cells promote cartilage regeneration, but do not permanently engraft in distant organs[J]. Sci Rep, 2019, 9(1):10153.
38
He J, Liu Y, Zhang L, et al. Exosomes secreted by ADMSCs preserve cartilage integrity in knee osteoarthritis via AMPK-mediated mitochondrial dynamics and apoptosis[J]. Stem Cells, 2026, 22: sxag021.
39
Li F, Xu Z, Xie Z, et al. Adipose mesenchymal stem cells-derived exosomes alleviate osteoarthritis by transporting microRNA -376c-3p and targeting the WNT-beta-catenin signaling axis[J]. Apoptosis, 2023, 28(3-4):362-378.
40
Wang Y, Fan A, Lu L, et al. Exosome modification to better alleviates endoplasmic reticulum stress induced chondrocyte apoptosis and osteoarthritis[J]. Biochem Pharmacol, 2022, 206:115343.
41
王斌, 邢丹, 董圣杰, 等. 中国膝骨关节炎流行病学和疾病负担的系统评价[J]. 中国循证医学杂志, 2018, 18(2):134-142.
[1] 吉宇通, 周月惠, 卫杨文祥, 陈镇秋, 王海彬, 周驰. 滑膜巨噬细胞铁调素诱发软骨细胞铁死亡的机制研究[J/OL]. 中华关节外科杂志(电子版), 2026, 20(03): 322-333.
[2] 王博, 李全, 胡静, 李洋洋, 从嘉男, 海日罕, 曹胜军. 丝素蛋白修饰的羊脱细胞真皮基质复合人脂肪间充质干细胞膜片对小鼠全层皮肤缺损创面的影响及其机制[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(04): 289-298.
[3] 李阳, 黄野, 曹光磊, 柳剑, 刘源, 龚龙, 谢文勇. 双间室膝关节单髁置换术在膝骨关节炎阶梯化治疗中的作用及研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2026, 21(04): 299-303.
[4] 夏明宇, 刘光昊, 孙倩男, 刘宾, 王道荣. 基于炎症与营养指标的早发型直肠癌患者预后列线图的构建与验证[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 468-473.
[5] 张宇, 夏晓天, 郭明高, 樊友本. 两种术式治疗甲状腺微小乳头状癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 480-484.
[6] 黄丛秀, 王少军, 郁志龙, 苏乌云, 刘彩霞, 孙晓革. 局部晚期非小细胞肺癌放疗联合免疫治疗并发治疗相关性肺炎的危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(04): 566-571.
[7] 王金强, 王妮妮, 陈荣荣, 张诚实, 张青, 冯契靓, 刘明, 程联云, 赵云峰, 雷撼, 秦二云. PIV、PLR联合D-二聚体及肌钙蛋白I对123例急性肺栓塞危险分层的回顾性研究[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(04): 586-592.
[8] 丁海斌, 刘爽, 乔丹, 李新涛, 陈艳妮, 程蒿, 刘佳. 外周血炎症指数预测148例局部晚期NSCLC免疫化疗后MPR的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(04): 600-606.
[9] 姜海珍, 江煜焓, 张丹, 陈晨晨. 骨髓间充质干细胞外泌体调控TLR4/NF-κB信号通路缓解小鼠子宫内膜异位症研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(03): 140-149.
[10] 徐莹, 吴逸璐, 金畅, 金毅, 陈萍, 汤月秋, 杨蓉, 任连升, 朱丹. 度拉糖肽联合达格列净对2型糖尿病肾脏疾病患者肾脏功能及纤维化的影响[J/OL]. 中华肾病研究电子杂志, 2026, 15(04): 188-194.
[11] 罗子嫣, 王婷, 蒋梅, 郑蜜蜜, 胡娟. 血液灌流治疗对维持性血液透析患者微炎症状态的影响研究进展[J/OL]. 中华肾病研究电子杂志, 2026, 15(04): 206-212.
[12] 张竹, 熊宇君, 蒋楹. 幽门螺杆菌感染与LS7指标的关联、炎症中介及性别差异研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(04): 308-313.
[13] 王茂盛, 康清源, 肖文韬, 王海东, 袁平, 张克石, 毛天明, 关振鹏. 基于遗传与代谢组学初步分析rs1426371在膝骨关节炎与动脉硬化共患病中的作用[J/OL]. 中华临床医师杂志(电子版), 2026, 20(04): 256-264.
[14] 常琼方, 胡馨怡, 冯荻, 刘娟芳, 张建好. C反应蛋白、中性粒细胞与淋巴细胞比值与胎盘植入球囊阻断术后穿刺相关下肢动脉血栓形成的相关性[J/OL]. 中华介入放射学电子杂志, 2026, 14(03): 265-271.
[15] 曾陈颖, 陈云清, 徐祖兵, 余求龙, 林晶, 洪道俊, 涂琪. 炎症标志物在大梗死核心与非大梗死核心急性缺血性脑卒中行血管内治疗的预后价值[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(04): 372-379.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?